BioSpace News Archive

icotec ag, a leading medical device manufacturer of Carbon/PEEK implants, strategically corporates with G-21 to distribute their bone cements in conjunction with icotec’s VADER® Pedicle Screw System in the United States.

iA’s Symphony Software platform will integrate the BD Rowa™ Pouch Packaging Solution, expanding iA’s solutions offering to include compliance packaging

As we put the series of calamities that was 2020 behind us, many will pop a bottle of Champagne in celebration.

The National Kidney Foundation’s Kidney Disease Outcomes Quality initiative reviews latest recommendations

Veracyte, Inc . (Nasdaq: VCYT) announced new preliminary performance data for its noninvasive nasal swab test for early lung cancer detection and its Percepta Genomic Atlas for informing treatment decisions at the time of diagnosis. Both tests are in development and scheduled to launch in

Laudio, a continuous performance management and engagement platform for health systems, today announced the launch of its newly formed strategic committee of trusted advisors. The committee includes distinguished healthcare leaders whose focus will be to help shape and guide the strategy and go-to-market priorities of Laudio, working closely with the leadership team. “Laudio’s strategic advisory committee will help guide our product roadmap and marke

Galt Pharmaceuticals announced the acquisition of a specialty branded product from Fortovia Therapeutics.

Loki Therapeutics, an immuno-oncology company developing next-generation cancer therapeutics that leverage childhood vaccination recall antigens, announced today its Chief Executive Officer Chris Bradley will participate in Biotech Showcase Digital and BIO @ JPM being held January 11-15, 2021 . Details of the events

Today, the U.S. Food and Drug Administration issued a new emergency use authorization (EUA) for the BinaxNOW COVID-19 Ag Card Home Test which is authorized for use by patients at home with a prescription.

This Proposed Pharma Grade Version of Tauri-Gum™ is Being Developed Specifically to Target: Patients Subjected to Ongoing Chemotherapy Treatment